Dr. Carolyn McIlree is an addiction medicine physician serving as Medical Director of the Opioid Treatment Programs for Baltimore's Pre-Trial Complex Opioid Treatment Programs.  Dr. McIlree is board-certified in addiction medicine and public health and general preventive medicine and has an MPH in epidemiology.  Dr. McIlree attended college at Stony Brook University and obtained a master's degree in psychology, where she studied working memory using functional magnetic resonance imaging (fMRI).  She earned her medical degree from the University of Vermont College of Medicine and completed residency training in public health and general preventive medicine at the University of Maryland Baltimore with an MPH in Epidemiology.  Dr. McIlree served as House Staff Officer for Quality Improvement & Patient Safety while a resident and completed Addiction Medicine Fellowship training at Caron Treatment Centers & Tower Health System's Reading Hospital.  Dr. McIlree has an interest in continuous quality improvement techniques to improve health care delivery and is pursuing Lean Six Sigma Greenbelt certification.  She is closely involved with implementation of House Bill 116 in the Baltimore Pre-Trial Complex, which establishes programs of screening, evaluation, and treatment of opioid use disorder in local correctional facilities.